These included the two novel cancer-related genes S100A4 and S100A10, both with various functions in tumor development and drug resistance, and the three genes IL7R, CCR7, and CXCR4 involved in tumor growth and migration pathways. This evidence concerns the gene S100A4 and neoplasm.